IL166273A0 - Methods of treatment of male erectile dysfunction - Google Patents

Methods of treatment of male erectile dysfunction

Info

Publication number
IL166273A0
IL166273A0 IL16627305A IL16627305A IL166273A0 IL 166273 A0 IL166273 A0 IL 166273A0 IL 16627305 A IL16627305 A IL 16627305A IL 16627305 A IL16627305 A IL 16627305A IL 166273 A0 IL166273 A0 IL 166273A0
Authority
IL
Israel
Prior art keywords
treatment
methods
erectile dysfunction
male erectile
male
Prior art date
Application number
IL16627305A
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/236,485 external-priority patent/US7105571B2/en
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of IL166273A0 publication Critical patent/IL166273A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
IL16627305A 2002-09-06 2005-01-13 Methods of treatment of male erectile dysfunction IL166273A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/236,485 US7105571B2 (en) 2000-01-10 2002-09-06 Prostaglandin compositions and methods of treatment for male erectile dysfunction
US48327803P 2003-06-27 2003-06-27
PCT/US2003/027885 WO2004022064A1 (en) 2002-09-06 2003-09-05 Methods of treatment of male erectile dysfunction

Publications (1)

Publication Number Publication Date
IL166273A0 true IL166273A0 (en) 2006-01-15

Family

ID=31980977

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16627305A IL166273A0 (en) 2002-09-06 2005-01-13 Methods of treatment of male erectile dysfunction

Country Status (10)

Country Link
EP (1) EP1534297A1 (en)
JP (1) JP2006512291A (en)
KR (1) KR20050057245A (en)
CN (1) CN1674912A (en)
AU (1) AU2003273291A1 (en)
CA (1) CA2493723A1 (en)
EA (1) EA200500452A1 (en)
IL (1) IL166273A0 (en)
NO (1) NO20050658L (en)
WO (1) WO2004022064A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
CN1774237A (en) * 2003-03-21 2006-05-17 尼克美制药控股有限公司 Angiogenesis promotion by prostaglandin compositions and methods
AU2004224413A1 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Prostaglandin compositions for the treatment of erectile dysfunction
EP3266458A1 (en) 2016-07-05 2018-01-10 Fagron B.V. Method and composition and kit for treating erectile dysfunction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
IL162154A0 (en) * 2002-02-15 2005-11-20 Nexmed Holdings Inc Prostagandin composition for the treatment of erectile dysfunction

Also Published As

Publication number Publication date
EP1534297A1 (en) 2005-06-01
JP2006512291A (en) 2006-04-13
NO20050658L (en) 2005-04-01
KR20050057245A (en) 2005-06-16
EA200500452A1 (en) 2005-10-27
CN1674912A (en) 2005-09-28
CA2493723A1 (en) 2004-03-18
AU2003273291A1 (en) 2004-03-29
WO2004022064A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
PL377729A1 (en) Method of the treatment of sexual dysfunction
IL153492A0 (en) Treatment of male sexual dysfunction
GB0225908D0 (en) Treatment of female sexual dysfunction
ZA200410009B (en) Compositions and methods for ameliorating of human female sexual dysfunction
AU2003219981A1 (en) Benzimidazole-derivatives for the treatment of sexual dysfunction
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
IL166273A0 (en) Methods of treatment of male erectile dysfunction
EP1677754A4 (en) Methods and compositions for treating erectile dysfunction
GB2408558B (en) Treatment of pipes
EP1648430A4 (en) Treatment of premature ejaculation
GB2386555B (en) Treatment of female sexual dysfunction
AU2002246924A8 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
IL155775A0 (en) Treatment of male sexual dysfunction
AU2003260818A8 (en) Treatment of immune system dysfunction
PL362980A1 (en) Treatment of sexual dysfunction
IL162822A0 (en) Treatment of male sexual dysfunction
GB0221712D0 (en) Methods of treatment
GB0323846D0 (en) Treatment of erectile dysfunction
GB0120679D0 (en) Treatment of male sexual dysfunction
GB0108730D0 (en) Treatment of male sexual dysfunction
GB0108483D0 (en) Treatment of male sexual dysfunction
GB0106167D0 (en) Treatment of male sexual dysfunction
AU2001281396A1 (en) Novel compositions and methods for treatment of male erectile dysfunction
GB0327975D0 (en) Methods of treatment
GB0316673D0 (en) Treatment of female sexual dysfunction